Selecting the right therapeutic target for kidney disease

Area of Science:

• Nephrology and Computational Biology
• Integrative omics and systems biology approaches for disease research

Background:

• Chronic kidney disease (CKD) presents complex pathophysiology with limited effective therapies to halt progression.
• The identification of novel disease drivers is crucial for developing effective CKD treatments.

Purpose of the Study:

• To present a holistic framework for identifying and validating disease drivers in CKD.
• To highlight recent scientific advances and technological innovations in CKD research.

Main Methods:

• Utilizing high-resolution patient-centric omics data.
• Employing advanced in silico tools including systems biology, connectivity mapping, and machine learning.
• Leveraging state-of-the-art experimental systems such as 3D in vitro models, CRISPR gene editing, and in vivo biological systems.

Main Results:

• The described framework integrates multi-omics data with computational and experimental approaches.
• This approach facilitates the identification of robust drug targets for CKD.
• Enhanced understanding of underlying disease mechanisms is achieved.

Conclusions:

• The proposed framework is expected to accelerate the discovery of novel drug candidates for CKD.
• Strong human target validation and mechanistic insights are key outcomes.
• This integrative approach holds promise for improving therapeutic strategies in kidney disease.